GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GLP-1 receptor agonism and GIP receptor antagonism induce substantial alterations in enteroendocrine and islet cell populations in obese high fat fed mice
Authors
Keywords
-
Journal
PEPTIDES
Volume 169, Issue -, Pages 171093
Publisher
Elsevier BV
Online
2023-09-01
DOI
10.1016/j.peptides.2023.171093
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
- (2023) Jing-Yue Wang et al. Frontiers in Endocrinology
- PYY (3-36) protects against high fat feeding induced changes of pancreatic islet and intestinal hormone content and morphometry
- (2023) A. Sridhar et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity
- (2023) Isabella Zaffina et al. Frontiers in Endocrinology
- Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
- (2023) Alice Adriaenssens et al. JCI Insight
- Tirzepatide Once Weekly for the Treatment of Obesity
- (2022) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alpha-cell paracrine signaling in the regulation of beta-cell insulin secretion
- (2022) Marlena M. Holter et al. Frontiers in Endocrinology
- Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats
- (2022) Ananyaa Sridhar et al. PLoS One
- Established and emerging roles peptide YY (PYY) and exploitation in obesity–diabetes
- (2021) Ryan A. Lafferty et al. Current Opinion in Endocrinology Diabetes and Obesity
- GIP receptor deletion in mice confers resistance to HFD-induced obesity via alterations in energy expenditure and adipose tissue lipid metabolism
- (2021) Geke Aline Boer et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The glucose-dependent insulinotropic polypeptide (GIP) regulates body weight and food intake via CNS-GIPR signaling
- (2021) Qian Zhang et al. Cell Metabolism
- Evidence for the existence and potential roles of intra-islet glucagon-like peptide-1
- (2021) Scott A. Campbell et al. Islets
- Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
- (2021) Neil Tanday et al. Frontiers in Endocrinology
- The Intestinal Epithelium – Fluid Fate and Rigid Structure From Crypt Bottom to Villus Tip
- (2021) Vangelis Bonis et al. Frontiers in Cell and Developmental Biology
- The evolving story of incretins ( GIP and GLP ‐1) in metabolic and cardiovascular disease: A pathophysiological update
- (2021) Michael A. Nauck et al. DIABETES OBESITY & METABOLISM
- Individual and combined effects of GIP and xenin on differentiation, glucose uptake and lipolysis in 3T3-L1 adipocytes
- (2020) Andrew English et al. BIOLOGICAL CHEMISTRY
- Dose‐dependent efficacy of the glucose‐dependent insulinotropic polypeptide ( GIP) receptor antagonist GIP (3‐30) NH 2 on GIP actions in humans
- (2020) Lærke Smidt Gasbjerg et al. DIABETES OBESITY & METABOLISM
- Chronic glucose-dependent insulinotropic polypeptide receptor (GIPR) agonism desensitizes adipocyte GIPR activity mimicking functional GIPR antagonism
- (2020) Elizabeth A. Killion et al. Nature Communications
- Targeting the GIPR for obesity: To agonize or antagonize? Potential mechanisms
- (2020) Jonathan E. Campbell Molecular Metabolism
- Function and mechanisms of enteroendocrine cells and gut hormones in metabolism
- (2019) Fiona M. Gribble et al. Nature Reviews Endocrinology
- Effects of long-acting GIP, xenin and oxyntomodulin peptide analogues on alpha-cell transdifferentiation in insulin-deficient diabetic GluCreERT2;ROSA26-eYFP mice
- (2019) Dipak Sarnobat et al. PEPTIDES
- Blockade of gastric inhibitory polypeptide (GIP) action as a novel means of countering insulin resistance in the treatment of obesity-diabetes
- (2019) Nigel Irwin et al. PEPTIDES
- The influence of Glucose-dependent Insulinotropic Polypeptide (GIP) on human adipose tissue and fat metabolism: Implications for obesity, type 2 diabetes and Non-Alcoholic Fatty Liver Disease (NAFLD)
- (2019) Sravan K. Thondam et al. PEPTIDES
- A GIP/xenin hybrid in combination with exendin-4 improves metabolic status in db/db diabetic mice and promotes enduring antidiabetic benefits in high fat fed mice
- (2019) S.L. Craig et al. BIOCHEMICAL PHARMACOLOGY
- High fat diet induces microbiota-dependent silencing of enteroendocrine cells
- (2019) Lihua Ye et al. eLife
- Enteroendocrine cells switch hormone expression along the crypt-to-villus BMP signalling gradient
- (2018) Joep Beumer et al. NATURE CELL BIOLOGY
- Anti-obesity effects of GIPR antagonists alone and in combination with GLP-1R agonists in preclinical models
- (2018) Elizabeth A. Killion et al. Science Translational Medicine
- Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
- (2018) Piotr A. Mroz et al. Molecular Metabolism
- Enteroendocrine Cells: Chemosensors in the Intestinal Epithelium
- (2016) Fiona M. Gribble et al. Annual Review of Physiology
- Functional and Molecular Adaptations of Enteroendocrine L-Cells in Male Obese Mice Are Associated With Preservation of Pancreatic α-Cell Function and Prevention of Hyperglycemia
- (2016) Rodolphe Dusaulcy et al. ENDOCRINOLOGY
- Abundance and turnover of GLP-1 producing L-cells in ileal mucosa are not different in patients with and without type 2 diabetes
- (2016) Kirsten Kampmann et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
- (2016) Dawood Khan et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Intestinal and neuronal myenteric adaptations in the small intestine induced by a high-fat diet in mice
- (2015) Angelica Soares et al. BMC GASTROENTEROLOGY
- Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
- (2015) A H Sparre-Ulrich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Sequential induction of beta cell rest and stimulation using stable GIP inhibitor and GLP-1 mimetic peptides improves metabolic control in C57BL/KsJ db/db mice
- (2015) Varun Pathak et al. DIABETOLOGIA
- Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice
- (2015) V. Pathak et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy
- (2014) R. Charlotte Moffett et al. PLoS One
- Role of Endogenous GLP-1 and GIP in Beta Cell Compensatory Responses to Insulin Resistance and Cellular Stress
- (2014) Srividya Vasu et al. PLoS One
- A novel acylated form of (d-Ala2)GIP with improved antidiabetic potential, lacking effect on body fat stores
- (2013) Christine M.A. Martin et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance
- (2013) Niina Matikainen et al. DIABETES CARE
- Co-localisation and secretion of glucagon-like peptide 1 and peptide YY from primary cultured human L cells
- (2013) A. M. Habib et al. DIABETOLOGIA
- Transcriptional Regulatory Factor X6 (Rfx6) Increases Gastric Inhibitory Polypeptide (GIP) Expression in Enteroendocrine K-cells and Is Involved in GIP Hypersecretion in High Fat Diet-induced Obesity
- (2012) Kazuyo Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Peripheral and Central GLP-1 Receptor Populations Mediate the Anorectic Effects of Peripherally Administered GLP-1 Receptor Agonists, Liraglutide and Exendin-4
- (2011) Scott E. Kanoski et al. ENDOCRINOLOGY
- Peripheral-Specific Y2 Receptor Knockdown Protects Mice From High-Fat Diet–Induced Obesity
- (2011) Yan-chuan Shi et al. Obesity
- Increased β-cell volume in mice fed a high-fat diet: A dynamic study over 12 months
- (2011) Jonatan Ahrén et al. Islets
- Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice
- (2010) David W. Porter et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Metabolic effects of sustained activation of the GLP-1 receptor alone and in combination with background GIP receptor antagonism in high fat-fed mice
- (2009) N. Irwin et al. DIABETES OBESITY & METABOLISM
- The role of peptide YY in appetite regulation and obesity
- (2008) Efthimia Karra et al. JOURNAL OF PHYSIOLOGY-LONDON
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now